Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies.

Fuchimoto Y, Morikawa N, Kuroda T, Hirobe S, Kamagata S, Kumagai M, Matsuoka K, Morikawa Y.

Pediatr Int. 2012 Apr;54(2):285-7. doi: 10.1111/j.1442-200X.2011.03414.x. No abstract available.

PMID:
22507155
2.

Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine.

Barabash-Neila R, García-Rodríguez E, Bernabeu-Wittel J, Bueno-Rodríguez I, Ramírez-Villar G, López-Gutierrez JC.

Indian J Pediatr. 2012 Oct;79(10):1386-7. doi: 10.1007/s12098-011-0625-4. Epub 2011 Dec 10. No abstract available.

PMID:
22161581
3.

Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.

Jahnel J, Lackner H, Reiterer F, Urlesberger B, Urban C.

Klin Padiatr. 2012 Oct;224(6):395-7. doi: 10.1055/s-0032-1323823. Epub 2012 Oct 15. No abstract available.

PMID:
23070861
4.

Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.

Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L, Mariani G.

J Vasc Interv Radiol. 2012 Mar;23(3):417-22. doi: 10.1016/j.jvir.2011.12.007.

PMID:
22365299
5.

Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.

Wang Z, Li K, Dong K, Xiao X, Zheng S.

J Pediatr Hematol Oncol. 2015 Jan;37(1):72-3. doi: 10.1097/MPH.0000000000000068. No abstract available.

PMID:
24309604
6.

Rapidly enlarging "bruise" on the back of an infant. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt syndrome.

Chan S, Cassarino DS.

JAMA Dermatol. 2013 Nov;149(11):1337-8. doi: 10.1001/jamadermatol.2013.519. No abstract available.

PMID:
24005816
7.

Comment on: Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up.

Adams DM, Hammill AM, Mobberley-Schuman PS, Trenor CC 3rd.

Pediatr Blood Cancer. 2015 Nov;62(11):2056. doi: 10.1002/pbc.25609. Epub 2015 Jun 5. No abstract available.

PMID:
26052679
8.

Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis.

Blei F.

Pediatr Blood Cancer. 2015 Apr;62(4):551-2. doi: 10.1002/pbc.25365. Epub 2015 Jan 5. No abstract available.

PMID:
25559734
9.

Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.

Wang Z, Li K, Yao W, Dong K, Xiao X, Zheng S.

Pediatr Blood Cancer. 2015 Apr;62(4):577-80. doi: 10.1002/pbc.25296. Epub 2014 Oct 24.

PMID:
25346262
10.

Successful treatment of Kaposiform hemangioendothelioma with everolimus.

Uno T, Ito S, Nakazawa A, Miyazaki O, Mori T, Terashima K.

Pediatr Blood Cancer. 2015 Mar;62(3):536-8. doi: 10.1002/pbc.25241. Epub 2014 Oct 12.

PMID:
25306933
11.

Giant vascular malformation with thrombocytopenia in a newborn.

Downing A, Chauhan A, Lotterman C, Craver R, Warrier R.

Clin Pediatr (Phila). 2013 Nov;52(11):1079-82. doi: 10.1177/0009922813501225. Epub 2013 Sep 3. No abstract available.

PMID:
24002050
12.

Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.

Matsumoto H, Ozeki M, Hori T, Kanda K, Kawamoto N, Nagano A, Azuma E, Miyazaki T, Fukao T.

J Pediatr Hematol Oncol. 2016 Nov;38(8):e322-e325.

PMID:
26907642
13.

Capillary-lymphatic malformation, kaposiform hemangioendothelioma and delayed Kasabach-Merritt phenomenon.

del Pozo J, López-Gutiérrez JC, Gómez-Tellado M, Nistal M, Soler R, Sacristán F, Tovar JA.

Pediatr Dermatol. 2011 Jul-Aug;28(4):439-43. doi: 10.1111/j.1525-1470.2010.01089.x. Epub 2010 Apr 9.

PMID:
20403115
14.

Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.

Ji Y, Chen S, Xiang B, Li K, Xu Z, Yao W, Lu G, Liu X, Xia C, Wang Q, Li Y, Wang C, Yang K, Yang G, Tang X, Xu T, Wu H.

Int J Cancer. 2017 Aug 15;141(4):848-855. doi: 10.1002/ijc.30775. Epub 2017 May 26.

PMID:
28486787
15.

[Kaposiform hemangioendothelioma in a neonate associated with Kasabach-Merritt phenomenon: case report].

Huang X, Wei B, Jiang Y.

Zhonghua Er Ke Za Zhi. 2015 Oct;53(10):790-1. Chinese. No abstract available.

PMID:
26758119
16.

Clinical Outcomes for Systemic Corticosteroids Versus Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma.

Liu X, Li J, Qu X, Yan W, Zhang L, Zhang S, Yang C, Zheng J.

Medicine (Baltimore). 2016 May;95(20):e3431. doi: 10.1097/MD.0000000000003431. Review.

17.

Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery.

Jiang RS, Hu R.

Int J Clin Oncol. 2012 Oct;17(5):512-6. doi: 10.1007/s10147-011-0321-4. Epub 2011 Sep 28.

PMID:
21947597
18.

Successful Propranolol Treatment of a Kaposiform Hemangioendothelioma Apparently Resistant to Propranolol.

Filippi L, Tamburini A, Berti E, Perrone A, Defilippi C, Favre C, Calvani M, Della Bona ML, la Marca G, Donzelli G.

Pediatr Blood Cancer. 2016 Jul;63(7):1290-2. doi: 10.1002/pbc.25979. Epub 2016 Apr 21.

PMID:
27100060
19.

Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.

Wang Z, Li K, Dong K, Xiao X, Zheng S.

Pediatr Blood Cancer. 2014 Aug;61(8):1518-9. doi: 10.1002/pbc.24957. Epub 2014 Jan 30. No abstract available.

PMID:
24482015
20.

Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment.

Hermans DJ, van Beynum IM, van der Vijver RJ, Kool LJ, de Blaauw I, van der Vleuten CJ.

J Pediatr Hematol Oncol. 2011 May;33(4):e171-3. doi: 10.1097/MPH.0b013e3182152e4e.

PMID:
21516018

Supplemental Content

Support Center